Search

Your search keyword '"Mokhtari, Karima"' showing total 921 results
Start Over Author "Mokhtari, Karima"
921 results on '"Mokhtari, Karima"'

51. Supplementary Tables S1-S3 from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

Author

Ko, Aram, primary, Hasanain, Mohammad, primary, Oh, Young Taek, primary, D'Angelo, Fulvio, primary, Sommer, Danika, primary, Frangaj, Brulinda, primary, Tran, Suzanne, primary, Bielle, Franck, primary, Pollo, Bianca, primary, Paterra, Rosina, primary, Mokhtari, Karima, primary, Soni, Rajesh Kumar, primary, Peyre, Matthieu, primary, Eoli, Marica, primary, Papi, Laura, primary, Kalamarides, Michel, primary, Sanson, Marc, primary, Iavarone, Antonio, primary, and Lasorella, Anna, primary

Published
2023
Full Text
View/download PDF

52. Supplementary Figure S1. from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

Author

Ko, Aram, primary, Hasanain, Mohammad, primary, Oh, Young Taek, primary, D'Angelo, Fulvio, primary, Sommer, Danika, primary, Frangaj, Brulinda, primary, Tran, Suzanne, primary, Bielle, Franck, primary, Pollo, Bianca, primary, Paterra, Rosina, primary, Mokhtari, Karima, primary, Soni, Rajesh Kumar, primary, Peyre, Matthieu, primary, Eoli, Marica, primary, Papi, Laura, primary, Kalamarides, Michel, primary, Sanson, Marc, primary, Iavarone, Antonio, primary, and Lasorella, Anna, primary

Published
2023
Full Text
View/download PDF

53. Data from LZTR1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

Author

Ko, Aram, primary, Hasanain, Mohammad, primary, Oh, Young Taek, primary, D'Angelo, Fulvio, primary, Sommer, Danika, primary, Frangaj, Brulinda, primary, Tran, Suzanne, primary, Bielle, Franck, primary, Pollo, Bianca, primary, Paterra, Rosina, primary, Mokhtari, Karima, primary, Soni, Rajesh Kumar, primary, Peyre, Matthieu, primary, Eoli, Marica, primary, Papi, Laura, primary, Kalamarides, Michel, primary, Sanson, Marc, primary, Iavarone, Antonio, primary, and Lasorella, Anna, primary

Published
2023
Full Text
View/download PDF

54. S1: Genetic landscape of MDM2/TP53 pathway. from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Author

Verreault, Maite, primary, Schmitt, Charlotte, primary, Goldwirt, Lauriane, primary, Pelton, Kristine, primary, Haidar, Samer, primary, Levasseur, Camille, primary, Guehennec, Jeremy, primary, Knoff, David, primary, Labussière, Marianne, primary, Marie, Yannick, primary, Ligon, Azra H., primary, Mokhtari, Karima, primary, Hoang-Xuan, Khê, primary, Sanson, Marc, primary, Alexander, Brian M., primary, Wen, Patrick Y., primary, Delattre, Jean-Yves, primary, Ligon, Keith L., primary, and Idbaih, Ahmed, primary

Published
2023
Full Text
View/download PDF

55. Supplementary Table 1 from Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas

Author

Gonzalez-Aguilar, Alberto, primary, Idbaih, Ahmed, primary, Boisselier, Blandine, primary, Habbita, Naïma, primary, Rossetto, Marta, primary, Laurenge, Alice, primary, Bruno, Aurélie, primary, Jouvet, Anne, primary, Polivka, Marc, primary, Adam, Clovis, primary, Figarella-Branger, Dominique, primary, Miquel, Catherine, primary, Vital, Anne, primary, Ghesquières, Hervé, primary, Gressin, Rémy, primary, Delwail, Vincent, primary, Taillandier, Luc, primary, Chinot, Olivier, primary, Soubeyran, Pierre, primary, Gyan, Emmanuel, primary, Choquet, Sylvain, primary, Houillier, Caroline, primary, Soussain, Carole, primary, Tanguy, Marie-Laure, primary, Marie, Yannick, primary, Mokhtari, Karima, primary, and Hoang-Xuan, Khê, primary

Published
2023
Full Text
View/download PDF

56. S7: Additional material and methods from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Author

Verreault, Maite, primary, Schmitt, Charlotte, primary, Goldwirt, Lauriane, primary, Pelton, Kristine, primary, Haidar, Samer, primary, Levasseur, Camille, primary, Guehennec, Jeremy, primary, Knoff, David, primary, Labussière, Marianne, primary, Marie, Yannick, primary, Ligon, Azra H., primary, Mokhtari, Karima, primary, Hoang-Xuan, Khê, primary, Sanson, Marc, primary, Alexander, Brian M., primary, Wen, Patrick Y., primary, Delattre, Jean-Yves, primary, Ligon, Keith L., primary, and Idbaih, Ahmed, primary

Published
2023
Full Text
View/download PDF

57. Supplementary Figure 5 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

58. S5: MDM2, MDM4 and TP53 gene expression in the GBM cell lines of cohort #1 as determined by RT-qPCR. from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Author

Verreault, Maite, primary, Schmitt, Charlotte, primary, Goldwirt, Lauriane, primary, Pelton, Kristine, primary, Haidar, Samer, primary, Levasseur, Camille, primary, Guehennec, Jeremy, primary, Knoff, David, primary, Labussière, Marianne, primary, Marie, Yannick, primary, Ligon, Azra H., primary, Mokhtari, Karima, primary, Hoang-Xuan, Khê, primary, Sanson, Marc, primary, Alexander, Brian M., primary, Wen, Patrick Y., primary, Delattre, Jean-Yves, primary, Ligon, Keith L., primary, and Idbaih, Ahmed, primary

Published
2023
Full Text
View/download PDF

59. Supplementary Figure 2 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

60. S3: Evolution of MDM2 and TP53 status over time of 5 patients affected by MDM2-amplified GBM. from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Author

Verreault, Maite, primary, Schmitt, Charlotte, primary, Goldwirt, Lauriane, primary, Pelton, Kristine, primary, Haidar, Samer, primary, Levasseur, Camille, primary, Guehennec, Jeremy, primary, Knoff, David, primary, Labussière, Marianne, primary, Marie, Yannick, primary, Ligon, Azra H., primary, Mokhtari, Karima, primary, Hoang-Xuan, Khê, primary, Sanson, Marc, primary, Alexander, Brian M., primary, Wen, Patrick Y., primary, Delattre, Jean-Yves, primary, Ligon, Keith L., primary, and Idbaih, Ahmed, primary

Published
2023
Full Text
View/download PDF

61. Supplementary Figure 1 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

62. Supplementary Figure 6 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

63. Supplementary Figure Legends from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

64. Supplementary Figure 3 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

65. Supplementary Figure 4 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

66. S6: MDM2, MDM4 and p53 protein level in the GBM cell lines of cohort #1 as determined by western blot from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Author

Verreault, Maite, primary, Schmitt, Charlotte, primary, Goldwirt, Lauriane, primary, Pelton, Kristine, primary, Haidar, Samer, primary, Levasseur, Camille, primary, Guehennec, Jeremy, primary, Knoff, David, primary, Labussière, Marianne, primary, Marie, Yannick, primary, Ligon, Azra H., primary, Mokhtari, Karima, primary, Hoang-Xuan, Khê, primary, Sanson, Marc, primary, Alexander, Brian M., primary, Wen, Patrick Y., primary, Delattre, Jean-Yves, primary, Ligon, Keith L., primary, and Idbaih, Ahmed, primary

Published
2023
Full Text
View/download PDF

67. S2: Survival of GBM patients according to MDM2 status. from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Author

Verreault, Maite, primary, Schmitt, Charlotte, primary, Goldwirt, Lauriane, primary, Pelton, Kristine, primary, Haidar, Samer, primary, Levasseur, Camille, primary, Guehennec, Jeremy, primary, Knoff, David, primary, Labussière, Marianne, primary, Marie, Yannick, primary, Ligon, Azra H., primary, Mokhtari, Karima, primary, Hoang-Xuan, Khê, primary, Sanson, Marc, primary, Alexander, Brian M., primary, Wen, Patrick Y., primary, Delattre, Jean-Yves, primary, Ligon, Keith L., primary, and Idbaih, Ahmed, primary

Published
2023
Full Text
View/download PDF

68. S4: MDM2, MDM4, and TP53 gene statuses in the cell lines from Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas

Author

Verreault, Maite, primary, Schmitt, Charlotte, primary, Goldwirt, Lauriane, primary, Pelton, Kristine, primary, Haidar, Samer, primary, Levasseur, Camille, primary, Guehennec, Jeremy, primary, Knoff, David, primary, Labussière, Marianne, primary, Marie, Yannick, primary, Ligon, Azra H., primary, Mokhtari, Karima, primary, Hoang-Xuan, Khê, primary, Sanson, Marc, primary, Alexander, Brian M., primary, Wen, Patrick Y., primary, Delattre, Jean-Yves, primary, Ligon, Keith L., primary, and Idbaih, Ahmed, primary

Published
2023
Full Text
View/download PDF

69. Supplementary Table 1 from Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma

Author

Di Stefano, Anna Luisa, primary, Fucci, Alessandra, primary, Frattini, Veronique, primary, Labussiere, Marianne, primary, Mokhtari, Karima, primary, Zoppoli, Pietro, primary, Marie, Yannick, primary, Bruno, Aurelie, primary, Boisselier, Blandine, primary, Giry, Marine, primary, Savatovsky, Julien, primary, Touat, Mehdi, primary, Belaid, Hayat, primary, Kamoun, Aurelie, primary, Idbaih, Ahmed, primary, Houillier, Caroline, primary, Luo, Feng R., primary, Soria, Jean-Charles, primary, Tabernero, Josep, primary, Eoli, Marica, primary, Paterra, Rosina, primary, Yip, Stephen, primary, Petrecca, Kevin, primary, Chan, Jennifer A., primary, Finocchiaro, Gaetano, primary, Lasorella, Anna, primary, Sanson, Marc, primary, and Iavarone, Antonio, primary

Published
2023
Full Text
View/download PDF

70. CombiningMYD88 L265Pmutation detection and clonality determination on CSF cellular and cell‐free DNA improves diagnosis of primary CNS lymphoma

Author

Bravetti, Clotilde, primary, Degaud, Michaël, additional, Armand, Marine, additional, Sourdeau, Elise, additional, Mokhtari, Karima, additional, Maloum, Karim, additional, Osman, Jennifer, additional, Verrier, Patricia, additional, Houillier, Caroline, additional, Roos‐Weil, Damien, additional, Soussain, Carole, additional, Choquet, Sylvain, additional, Hoang‐Xuan, Khe, additional, Le Garff‐Tavernier, Magali, additional, Denis, Jérôme Alexandre, additional, and Davi, Frédéric, additional

Published
2023
Full Text
View/download PDF

74. Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement?

Author

Boluda, Susana, Mokhtari, Karima, Mégarbane, Bruno, Annane, Djillali, Mathon, Bertrand, Cao, Albert, Adam, Clovis, Androuin, Alexandre, Bielle, Franck, Brochier, Guy, Charlotte, Frédéric, Chougar, Lydia, El Hachimi, Khalid Hamid, Eloit, Marc, Haïk, Stéphane, Hervé, Dominique, Kasri, Amal, Leducq, Valentin, Lehéricy, Stéphane, Levavasseur, Etienne, Lobsiger, Christian, Lorin De La Grandmaison, Geoffroy, Malet, Isabelle, Malissin, Isabelle, Marot, Stéphane, Marty, Serge, Pérot, Philippe, Plu, Isabelle, Prigent, Annick, Stimmer, Lev, Potier, Marie-Claude, Marcelin, Anne-Geneviève, Delatour, Benoît, Duyckaerts, Charles, Seilhean, Danielle, Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Raymond Poincaré [Garches], Université Paris-Saclay, Infection et inflammation (2I), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Institut de Myologie, Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL), Découverte de pathogènes – Pathogen discovery, Institut Pasteur [Paris] (IP), Université Sorbonne Paris Nord, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), The authors thank the Cohort COVID-19 Neurosciences (CoCo Neurosciences) study supported by APHP and funded by the generous support of the Federation Internationale de l’Automobile (FIA), the FIA Foundation and donors of Paris Brain Institute – ICM. The research leading to these results has received funding from Sorbonne University (PathoCoV project) and from the program 'Investissements d’avenir' ANR-10- IAIHU-06. This work benefited from equipment and services from the CELIS cell culture core facility (Paris Brain Institute), a platform receiving support from ANR-10- IAIHU-06 and ANR-11-INBS-0011-NeurATRIS. We thank for targeted NGS sequencing the Biomics Platform, C2RT, Institut Pasteur, Paris, France, supported by France Génomique (ANR-10-INBS-09-09), IBISA and the Illumina COVID-19 Projects’ offer., ANR-10-IAHU-0006,IHU-A-ICM,Institut de Neurosciences Translationnelles de Paris(2010), ANR-11-INBS-0011,NeurATRIS,Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences(2011), and ANR-10-INBS-0009,France-Génomique,Organisation et montée en puissance d'une Infrastructure Nationale de Génomique(2010)

Subjects
Furin, Blood-brain barrier (BBB), Original Paper, Microangiopathy, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Neuro-Covid, [SDV.MHEP.AHA]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO], COVID-19
Abstract

In a neuropathological series of 20 COVID-19 cases, we analyzed six cases (three biopsies and three autopsies) with multiple foci predominantly affecting the white matter as shown by MRI. The cases presented with microhemorrhages evocative of small artery diseases. This COVID-19 associated cerebral microangiopathy (CCM) was characterized by perivascular changes: arterioles were surrounded by vacuolized tissue, clustered macrophages, large axonal swellings and a crown arrangement of aquaporin-4 immunoreactivity. There was evidence of blood-brain-barrier leakage. Fibrinoid necrosis, vascular occlusion, perivascular cuffing and demyelination were absent. While no viral particle or viral RNA was found in the brain, the SARS-CoV-2 spike protein was detected in the Golgi apparatus of brain endothelial cells where it closely associated with furin, a host protease known to play a key role in virus replication. Endothelial cells in culture were not permissive to SARS-CoV-2 replication. The distribution of the spike protein in brain endothelial cells differed from that observed in pneumocytes. In the latter, the diffuse cytoplasmic labeling suggested a complete replication cycle with viral release, notably through the lysosomal pathway. In contrast, in cerebral endothelial cells the excretion cycle was blocked in the Golgi apparatus. Interruption of the excretion cycle could explain the difficulty of SARS-CoV-2 to infect endothelial cells in vitro and to produce viral RNA in the brain. Specific metabolism of the virus in brain endothelial cells could weaken the cell walls and eventually lead to the characteristic lesions of COVID-19 associated cerebral microangiopathy. Furin as a modulator of vascular permeability could provide some clues for the control of late effects of microangiopathy., Free Neuropathology, Vol. 4 (2023)

Published
2023

75. LZTR1 mutation mediates oncogenesis through stabilization of EGFR and AXL

Author

Ko, Aram, primary, Hasanain, Mohammad, additional, Oh, Young Taek, additional, D'Angelo, Fulvio, additional, Sommer, Danika, additional, Frangaj, Brulinda, additional, Tran, Suzanne, additional, Bielle, Franck, additional, Pollo, Bianca, additional, Paterra, Rosina, additional, Mokhtari, Karima, additional, Soni, Rajesh Kumar., additional, Peyre, Matthieu, additional, Eoli, Marica, additional, Papi, Laura, additional, Kalamarides, Michel, additional, Sanson, Marc, additional, Iavarone, Antonio, additional, and Lasorella, Anna, additional

Published
2022
Full Text
View/download PDF

76. SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era

Author

Laurenge, Alice, primary, Ursu, Renata, additional, Tabouret, Emeline, additional, Harlay, Vincent, additional, Ahle, Guido, additional, Choquet, Sylvain, additional, Soussain, Carole, additional, Moluçon-Chabrot, Cécile, additional, Mathon, Bertrand, additional, Mokhtari, Karima, additional, Pourcher, Valérie, additional, Nichelli, Lucia, additional, Marot, Stéphane, additional, Touat, Mehdi, additional, Hoang-Xuan, Khê, additional, and Houillier, Caroline, additional

Published
2022
Full Text
View/download PDF

77. CSIG-01. EGFR AND AXL RECEPTOR TYROSINE KINASES DRIVE ONCOGENESIS BY LZTR1 MUTATION

Author

Ko, Aram, primary, Hasanain, Mohammad, additional, Oh, Young Taek, additional, D'Angelo, Fulvio, additional, Sommer, Danika, additional, Frangaj, Brulinda, additional, Tran, Suzanne, additional, Bielle, Franck, additional, Pollo, Bianca, additional, Paterra, Rosina, additional, Mokhtari, Karima, additional, Soni, Rajesh, additional, Peyre, Matthieu, additional, Eoli, Marica, additional, Kalamarides, Michel, additional, Sanson, Marc, additional, Iavarone, Antonio, additional, and Lasorella, Anna, additional

Published
2022
Full Text
View/download PDF

78. PATH-16. THRESHOLDS OF MITOTIC ACTIVITY AND POST-SURGERY RESIDUAL VOLUME ARE INDEPENDENT PROGNOSTIC FACTORS IN ASTROCYTOMA IDH-MUTANT

Author

Tran, Suzanne, primary, Thomas, Alice, additional, Touat, Mehdi, additional, Karachi, Carine, additional, Dehais, Caroline, additional, Feuvret, Loïc, additional, Mokhtari, Karima, additional, Sanson, Marc, additional, Idbaih, Ahmed, additional, Carpentier, Alexandre, additional, Hoang-Xuan, Khê, additional, Capelle, Laurent, additional, and Bielle, Franck, additional

Published
2022
Full Text
View/download PDF

80. Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell‐free DNA improves diagnosis of primary CNS lymphoma.

Author

Bravetti, Clotilde, Degaud, Michaël, Armand, Marine, Sourdeau, Elise, Mokhtari, Karima, Maloum, Karim, Osman, Jennifer, Verrier, Patricia, Houillier, Caroline, Roos‐Weil, Damien, Soussain, Carole, Choquet, Sylvain, Hoang‐Xuan, Khe, Le Garff‐Tavernier, Magali, Denis, Jérôme Alexandre, and Davi, Frédéric

Subjects
CELL-free DNA, MYELOID differentiation factor 88, IMMUNOGLOBULIN heavy chains, CIRCULATING tumor DNA, MOLECULAR diagnosis, LYMPHOMAS, CENTRAL nervous system, MENINGEAL cancer
Abstract

Summary: Diagnosis of primary central nervous system lymphoma (PCNSL) is challenging, and although brain biopsy remains the gold standard, cerebrospinal fluid (CSF) constitutes a less invasive source of lymphomatous biomarkers. In a retrospective cohort of 54 PCNSL cases tested at diagnosis or relapse, we evaluated the contribution of immunoglobulin heavy chain (IGH) gene clonality and MYD88 L265P detection on both CSF cell pellets and supernatants, in comparison with cytology, flow cytometry, interleukin (IL)‐10 and IL‐6 quantification. Clonality assessment included a new assay to detect partial IGH‐DJ rearrangements. Clonal IGH rearrangements and/or MYD88 L265P mutation were detected in 27 (50%) cell pellets and 24 (44%) supernatant cell‐free (cf) DNA. Combining analyses on both compartments, 36 (66%) cases had at least one detectable molecular marker, present only in cfDNA for 9 (16%) of them. While cytology and flow cytometry were positive in only 7 (13.0%) and 9 (17.3%) cases respectively, high IL‐10 levels were observed in 36 (66.7%) cases. Overall, taking into account molecular and cytokine results, 46/54 (85%) cases had at least one lymphomatous biomarker detectable in the CSF. These results show that this combination of biomarkers evaluated on both cell pellet and supernatant CSF fractions improves significantly the biological diagnosis of PCNSL. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

82. Le Port Nador West Med : Une locomotive et un levier stratégique pour la dynamique de la région de l'Oriental

Author

MOKHTARI, Karima and MIZAB, Hicham

Subjects
« Proximité », « Port Nador West Med », « Attractivité », « Région », « développement économique »
Abstract

Le Nord-Est du Maroc a été pendant longtemps marginalisé connaissant des disparités régionales, territoriales et économiques dispersées par rapport au centre du pays. Une nouvelle donne s’installe à l’heure actuelle avec le lancement essentiellement de plusieurs projets à grande portée tels que la Technopôle d’Oujda, l’Agropole de Berkane, Saidia- Fadesa… Un aménagement très imposant doit accompagner ces grands projets afin d’exploiter le potentiel de dynamisme de la Région. L’objectif de ce papier s’articule autour de la mesure des performances escomptées par la mise en place du Port NWM, et son effet sur le dynamisme de l’arrière-pays dans l’horizon 2034.Le complexe portuaire « Nador West Med » est une nouvelle infrastructure qui vient s’ajouter à la Région de l’Oriental, destiné à soutenir le développement économique et industriel dans l’arrière-pays, ainsi que le niveau de vie de la population locale. En se basant sur une étude approfondie sur l’impact de l’implantation du port Nador West Med, ce travail propose une description précise de l’infrastructure ainsi que l’impact escompté de son implantation à la fois sur la connectivité des infrastructures et sur l’attractivité économique et industrielle de l’Oriental.

Published
2022
Full Text
View/download PDF

83. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

Author

Tabouret, Emeline, Nguyen, Anh Tuan, Dehais, Caroline, Carpentier, Catherine, Ducray, François, Idbaih, Ahmed, Mokhtari, Karima, Jouvet, Anne, Uro-Coste, Emmanuelle, Colin, Carole, Chinot, Olivier, Loiseau, Hugues, Moyal, Elisabeth, Maurage, Claude-Alain, Polivka, Marc, Lechapt-Zalcman, Emmanuèle, Desenclos, Christine, Meyronet, David, Delattre, Jean-Yves, Figarella-Branger, Dominique, and For POLA Network

Published
2016
Full Text
View/download PDF

85. Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study

Author

Seyve, Antoine, primary, Dehais, Caroline, additional, Chinot, Olivier, additional, Djelad, Apolline, additional, Cohen-Moyal, Elisabeth, additional, Bronnimann, Charlotte, additional, Gourmelon, Carole, additional, Emery, Evelyne, additional, Colin, Philippe, additional, Boone, Mathieu, additional, Vauléon, Elodie, additional, Langlois, Olivier, additional, di Stefano, Anna-Luisa, additional, Seizeur, Romuald, additional, Ghiringhelli, François, additional, D’Hombres, Anne, additional, Feuvret, Loic, additional, Guyotat, Jacques, additional, Capelle, Laurent, additional, Carpentier, Catherine, additional, Garnier, Louis, additional, Honnorat, Jérôme, additional, Meyronet, David, additional, Mokhtari, Karima, additional, Figarella-Branger, Dominique, additional, and Ducray, François, additional

Published
2022
Full Text
View/download PDF

86. Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma

Author

Verreault, Maïté, primary, Segoviano Vilchis, Irma, additional, Rosenberg, Shai, additional, Lemaire, Nolwenn, additional, Schmitt, Charlotte, additional, Guehennec, Jérémy, additional, Royer‐Perron, Louis, additional, Thomas, Jean‐Léon, additional, Lam, TuKiet T., additional, Dingli, Florent, additional, Loew, Damarys, additional, Ducray, François, additional, Paris, Sophie, additional, Carpentier, Catherine, additional, Marie, Yannick, additional, Laigle‐Donadey, Florence, additional, Rousseau, Audrey, additional, Pigat, Natascha, additional, Boutillon, Florence, additional, Bielle, Franck, additional, Mokhtari, Karima, additional, Frank, Stuart J., additional, de Reyniès, Aurélien, additional, Hoang‐Xuan, Khê, additional, Sanson, Marc, additional, Goffin, Vincent, additional, and Idbaih, Ahmed, additional

Published
2022
Full Text
View/download PDF

87. Abstract 4014: Pathway based analysis of glioblastoma by multi-omics with applications in targeted therapy, prognosis and probabilistic classification

Author

Migliozzi, Simona, primary, Oh, Young Taek, additional, Garofano, Luciano, additional, Mohammad, Hasanain, additional, D'Angelo, Fulvio, additional, Najac, Ryan D., additional, Bielle, Franck, additional, Mokhtari, Karima, additional, Sarkaria, Jann N., additional, Ceccarelli, Michele, additional, Sanson, Marc, additional, Lasorella, Anna, additional, and Iavarone, Antonio, additional

Published
2022
Full Text
View/download PDF

89. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas

Author

Bielle, Franck, Ducray, François, Mokhtari, Karima, Dehais, Caroline, Adle‐Biassette, Homa, Carpentier, Catherine, Chanut, Anaïs, Polivka, Marc, Poggioli, Sylvie, Rosenberg, Shai, Giry, Marine, Marie, Yannick, Duyckaerts, Charles, Sanson, Marc, Figarella‐Branger, Dominique, Idbaih, Ahmed, Desenclos, Christine, Sevestre, Henri, Menei, Philippe, Rousseau, Audrey, Godard, Joel, Viennet, Gabriel, Carpentier, Antoine, Eimer, Sandrine, Loiseau, Hugues, Dam‐Hieu, Phong, Quintin‐Roué, Isabelle, Guillamo, Jean‐Sebastien, Lechapt‐Zalcman, Emmanuelle, Kemeny, Jean‐Louis, Khallil, Toufik, Cazals‐Hatem, Dominique, Faillot, Thierry, Carpiuc, Ioana, Richard, Pomone, Le Guerinel, Caroline, Gaultier, Claude, Tortel, Marie‐Christine, Aubriot‐Lorton, Marie‐Hélène, Ghiringhelli, François, Adam, Clovis, Parker, Fabrice, Maurage, Claude‐Alain, Ramirez, Carole, Marcel Gueye, Edouard, Labrousse, François, Jouvet, Anne, Chinot, Olivier, Bauchet, Luc, Rigau, Valérie, Beauchesne, Patrick, Gauchotte, Guillaume, Campone, Mario, Loussouarn, Delphine, Fontaine, Denys, Vandenbos, Fanny, Blechet, Claire, Fesneau, Mélanie, Yves Delattre, Jean, Elouadhani‐Hamdi, Selma, Ricard, Damien, Larrieu‐Ciron, Delphine, Levillain, Pierre‐Marie, Colin, Philippe, Diebold, Marie‐Danièle, Chiforeanu, Danchristian, Vauléon, Elodie, Langlois, Olivier, Laquerrière, Annie, Motsuo Fotso, Marie Janette, Peocʼh, Michel, Andraud, Marie, Runavot, Gwenaelle, Chenard, Marie‐Pierre, Noel, Georges, Gaillard, Stéphane, Villa, Chiara, Desse, Nicolas, Cohen‐Moyal, Elisabeth, Uro‐Coste, Emmanuelle, and Dhermain, Frédéric

Published
2017
Full Text
View/download PDF

90. Positron Emission Tomography/Computed Tomography Imaging of Residual Skull Base Chordoma Before Radiotherapy Using Fluoromisonidazole and Fluorodeoxyglucose: Potential Consequences for Dose Painting

Author

Mammar, Hamid, Kerrou, Khaldoun, Nataf, Valérie, Pontvert, Dominique, Clemenceau, Stéphane, Lot, Guillaume, George, Bernard, Polivka, Marc, Mokhtari, Karima, Ferrand, Regis, Feuvret, Loïc, Habrand, Jean-louis, Pouysségur, Jacques, Mazure, Nathalie, and Talbot, Jean-Noël

Published
2012
Full Text
View/download PDF

93. VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab

Author

Di Stefano, Anna Luisa, Labussiere, Marianne, Lombardi, Giuseppe, Eoli, Marica, Bianchessi, Donata, Pasqualetti, Francesco, Farina, Patrizia, Cuzzubbo, Stefania, Gallego-Perez-Larraya, Jaime, Boisselier, Blandine, Ducray, Francois, Cheneau, Caroline, Moglia, Arrigo, Finocchiaro, Gaetano, Marie, Yannick, Rahimian, Amithys, Hoang-Xuan, Khe, Delattre, Jean Yves, Mokhtari, Karima, and Sanson, Marc

Published
2015
Full Text
View/download PDF

94. Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours

Author

Appay, Romain, primary, Bielle, Franck, additional, Sievers, Philipp, additional, Barets, Doriane, additional, Fina, Frédéric, additional, Boutonnat, Jean, additional, Adam, Clovis, additional, Gauchotte, Guillaume, additional, Godfraind, Catherine, additional, Lhermitte, Benoît, additional, Maurage, Claude‐Alain, additional, Meyronet, David, additional, Mokhtari, Karima, additional, Rousseau, Audrey, additional, Tauziède‐Espariat, Arnault, additional, Tortel, Marie‐Claire, additional, Uro‐Coste, Emmanuelle, additional, Burel‐Vandenbos, Fanny, additional, Chotard, Guillaume, additional, Pesce, Florian, additional, Varlet, Pascale, additional, Colin, Carole, additional, and Figarella‐Branger, Dominique, additional

Published
2022
Full Text
View/download PDF

95. Severity, timeline, and management of complications after stereotactic brain biopsy

Author

Riche, Maximilien, primary, Marijon, Pauline, additional, Amelot, Aymeric, additional, Bielle, Franck, additional, Mokhtari, Karima, additional, Chambrun, Marc Pineton de, additional, Joncour, Alexandre Le, additional, Idbaih, Ahmed, additional, Touat, Mehdi, additional, Do, Chung-Hi, additional, Deme, Mamadou, additional, Pasqualotto, Romain, additional, Jacquens, Alice, additional, Degos, Vincent, additional, Shotar, Eimad, additional, Chougar, Lydia, additional, Carpentier, Alexandre, additional, and Mathon, Bertrand, additional

Published
2022
Full Text
View/download PDF

98. The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre

Author

Delorme, Cécile, Houot, Marion, Rosso, Charlotte, Carvalho, Stéphanie, Nedelec, Thomas, Maatoug, Redwan, Pitron, Victor, Gassama, Salimata, Sambin, Sara, Bombois, Stéphanie, Herlin, Bastien, Ouvrard, Gaëlle, Bruneteau, Gaëlle, Hesters, Adèle, Gales, Ana Zenovia, Millet, Bruno, Lamari, Foudil, Lehericy, Stéphane, Navarro, Vincent, Rohaut, Benjamin, Demeret, Sophie, Maisonobe, Thierry, Yger, Marion, Degos, Bertrand, Mariani, Louise-Laure, Bouche, Christophe, Dzierzynski, Nathalie, Oquendo, Bruno, Ketz, Flora, Nguyen, An-Hung, Kas, Aurélie, Lubetzki, Catherine, Delattre, Jean-Yves, Corvol, Jean-Christophe, Fontaine, Bertrand, Thoumie, Philippe, Sharshar, Tarek, Alamowitch, Sonia, Apartis-Bourdieu, Emmanuelle, Peretti, Charles-Siegried, Ursu, Renata, Bourron, Kiyoka Kinugawa, Belmin, Joel, Pautas, Eric, Verny, Marc, Samson, Yves, Leder, Sara, Leger, Anne, Deltour, Sandrine, Baronnet, Flore, Touat, Mehdi, Sanson, Marc, Dehais, Caroline, Houillier, Caroline, Laigle-Donadey, Florence, Psimaras, Dimitri, Alenton, Agusti, Younan, Nadia, Villain, Nicolas, Del Mar Amador, Maria, Mezouar, Nicolas, Mangone, Graziella, Meneret, Aurelie, Hartmann, Andreas, Tarrano, Clement, Bendetowicz, David, Pradat, Pierre-François, Baulac, Michel, Pichit, Phintip, Chochon, Florence, Nguyen, An Hung, Porcher, Valerie, Demoule, Alexandre, Morawiec, Elise, Mayaux, Julien, Faure, Morgan, Ewenczyk, Claire, Coarelli, Giulia, Heinzmann, Anna, Masingue, Marion, Bassez, Guillaume, An, Isabelle, Worbe, Yulia, Lambrecq, Virginie, Debs, Rabab, Musat, Esteban Munoz, Lenglet, Timothee, Hanin, Aurelie, Chougar, Lydia, Shor, Nathalia, Pyatigorskaya, Nadya, Galanaud, Damien, Leclercq, Delphine, Cao, Albert, Marois, Clemence, Weiss, Nicolas, Le Guennec, Loic, Degos, Vincent, Jacquens, Alice, Similowski, Thomas, Morelot-Panzini, Capucine, Rotge, Jean-Yves, Saudreau, Bertrand, Sarni, Nassim, Girault, Nathalie, Leu, Smaranda, Thivard, Lionel, Mokhtari, Karima, Plu, Isabelle, Gonçalves, Bruno, Bottin, Laure, Haddad, Rebecca, Lafuente, Carmelo, Oasi, Christel, Megabarne, Bruno, Herve, Dominique, Salman, Haysam, Rametti-Lacroux, Armelle, Chalançon, Alize, Herve, Anais, Royer, Hugo, Beauzor, Florence, Maheo, Valentine, Laganot, Christelle, Minelli, Camille, Fekete, Aurelie, Grine, Abel, Biet, Marie, Hilab, Rania, Besnard, Aurore, Bouguerra, Meriem, Goudard, Gwen, Houairi, Saida, Al-Youssef, Saba, Pires, Christine, Oukhedouma, Anissa, Siuda-Krzywicka, Katarzyna, Malkinson, Tal Seidel, Agguini, Hanane, Said, Safia, Gales, Ana, Brochard, Vanessa, Bourron, Kiyoka, Nguyen, An, Musat, Esteban, Malkinson, Tal, Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Service de Neurologie [CHU Pitié-Salpêtrière], IFR70-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de psychiatrie adulte [CHU Pitié-Salpêtière], CHU Pitié-Salpêtrière [AP-HP], Institut de la Mémoire et de la Maladie d'Alzheimer [Paris] (IM2A), Sorbonne Université (SU), Hôpital Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Service des Pathologies du sommeil [CHU Pitié-Salpêtrière], Service de Biochimie Métabolique [CHU Pitié-Salpêtrière], Service de Neuroradiologie [CHU Pitié-Salpêtrière], Service de Neurophysiologie [CHU Pitié-Salpêtrière], Service des Soins Intensifs [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Médecine Gériatrique [CHU Pitié-Salpêtrière], Service d'Activités cliniques [CHU Pitié-Salpêtrière], Service de médecine nucléaire [CHU Pitié-Salpétrière], Service de neurologie 1 [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Centre de Recherche en Myologie, and Service de gériatrie [CHU Pitié-Salpêtrière]

Subjects
Pediatrics, medicine.medical_specialty, encephalitis, Encephalopathy, Context (language use), law.invention, 03 medical and health sciences, Cellular and Molecular Neuroscience, 0302 clinical medicine, law, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Intensive care, medicine, Critical illness polyneuropathy, Biological Psychiatry, 030304 developmental biology, 0303 health sciences, business.industry, AcademicSubjects/SCI01870, COVID-19, medicine.disease, encephalopathy, Comorbidity, Intensive care unit, 3. Good health, Psychiatry and Mental health, Neurology, Observational study, Original Article, AcademicSubjects/MED00310, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], business, critical illness neuropathy, 030217 neurology & neurosurgery, Encephalitis
Abstract

A variety of neuropsychiatric complications has been described in association with Covid-19 infection. Large scale studies presenting a wider picture of these complications and their relative frequency are lacking. The objective of our study was to describe the spectrum of neurological and psychiatric complications in patients with Covid-19 seen in a multidisciplinary hospital center over six months. We conducted a retrospective, observational study on all patients showing neurological or psychiatric symptoms in the context of Covid-19 seen in the medical and university neuroscience department of Assistance Publique Hopitaux de Paris -Sorbonne University. We collected demographic data, comorbidities, symptoms and severity of Covid-19 infection, neurological and psychiatric symptoms, neurological and psychiatric examination data and, when available, results from CSF analysis, MRI, EEG and EMG. A total of 249 Covid-19 patients with a de novo neurological or psychiatric manifestation were included in the database and 245 were included in the final analyses. One-hundred fourteen patients (47%) were admitted to the intensive care unit and 10 (4%) died. The most frequent neuropsychiatric complications diagnosed were encephalopathy (43%), critical illness polyneuropathy and myopathy (26%), isolated psychiatric disturbance (18%), and cerebrovascular disorders (16%). No patients showed CSF evidence of SARS-CoV-2. Encephalopathy was associated with older age and higher risk of death. Critical illness neuromyopathy was associated with an extended stay in the intensive care unit. The majority of these neuropsychiatric complications could be imputed to critical illness, intensive care and systemic inflammation, which contrasts with the paucity of more direct SARS-CoV-2-related complications or post-infection disorders., Graphical Abstract Graphical Abstract

Published
2021

99. Growth Hormone Receptor (GHR) is overexpressed in low EGFR expressing glioblastoma and promotes tumor growth

Author

Vilchis, Irma Segoviano, primary, Verreault, Maite, additional, Lemaire, Nolwenn, additional, Pigat, Natasha, additional, Boutillon, Florence, additional, Bielle, Franck, additional, Mokhtari, Karima, additional, Frank, Stuart J., additional, Hoang-Xuan, Khe, additional, Sanson, Marc, additional, Delattre, Jean-Yves, additional, Goffin, Vincent, additional, and Idbaih, Ahmed, additional

Published
2022
Full Text
View/download PDF

100. Pathway based analysis of glioblastoma by multi-omics with applications in targeted therapy, prognosis and probabilistic classification

Author

Oh, Young Taek, primary, Migliozzi, Simona, additional, Garofano, Luciano, additional, Mohammad, Hasanain, additional, D’Angelo, Fulvio, additional, Najac, Ryan D., additional, Bielle, Franck, additional, Mokhtari, Karima, additional, Sarkaria, Jann N., additional, Ceccarelli, Michele, additional, Sanson, Marc, additional, Lasorella, Anna, additional, and Iavarone, Antonio, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results